Skip to main content

Table 1 Analysis of serumapo A-I in the entire patients

From: Comparison of serum apolipoprotein A-I between Chinese multiple sclerosis and other related autoimmune disease

Group***

MS

CIS

GBS

Viral encephalitis

SLE

RA

Healthy controls

Gender**(female:male)

32:28

19:19

10:18

26:25

22:14

20:15

27:32

Mean age ± SD*(years)

35.9 ± 14.8

36.0 ± 18.3

36.2 ± 20.0

30.0 ± 13.7

31.6 ± 10.7

36.3 ± 9.8

35.7 ± 10.2

Apo A-I (g/L)

1.392 ± 0.047

1.388 ± 0.058

1.282 ± 0.071

1.151 ± 0.051

0.940 ± 0.061

1.03 ± 0.061

1.179 ± 0.047

  1. MS = multiple sclerosis; SLE = systemic lupus erythematosus; RA = rheumatoid arthritis; CIS = Clinically Isolated Syndrome; GBS = Guillain--Barre Syndrome; apoA-I = apolipoproteinA-I.
  2. Data are means ± SD.* No significant differences, multivarite ANOVA, P = 0.755(P > 0.05). There was no significant effect of age on serum apoA-I levels in different disease groups. ** Significantly different, multivarite ANOVA. P = 0.04(P < 0.05). There was significant effect of sex on serum apoA-I levels. ***Significantly different, multivarite ANOVA. P < 0.001. There was significant effect of gender on serum apoA-I levels.